MeVis Medical Solutions AG (FRA:M3V)
Germany flag Germany · Delayed Price · Currency is EUR
25.20
0.00 (0.00%)
At close: May 30, 2025, 10:00 PM CET

FRA:M3V Statistics

Total Valuation

FRA:M3V has a market cap or net worth of EUR 45.86 million. The enterprise value is 43.30 million.

Market Cap 45.86M
Enterprise Value 43.30M

Important Dates

The last earnings date was Tuesday, May 27, 2025.

Earnings Date May 27, 2025
Ex-Dividend Date Mar 26, 2025

Share Statistics

Current Share Class 1.82M
Shares Outstanding n/a
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 479,388

Valuation Ratios

The trailing PE ratio is 10.66.

PE Ratio 10.66
Forward PE n/a
PS Ratio 2.76
PB Ratio 2.57
P/TBV Ratio 2.57
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 10.06
EV / Sales 2.60
EV / EBITDA 12.30
EV / EBIT 12.85
EV / FCF n/a

Financial Position

The company has a current ratio of 4.21

Current Ratio 4.21
Quick Ratio 3.70
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is 24.14% and return on invested capital (ROIC) is 11.81%.

Return on Equity (ROE) 24.14%
Return on Assets (ROA) 8.64%
Return on Invested Capital (ROIC) 11.81%
Return on Capital Employed (ROCE) 15.29%
Revenue Per Employee 145,927
Profits Per Employee 37,745
Employee Count 100
Asset Turnover 0.68
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -4.55% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -4.55%
50-Day Moving Average 25.85
200-Day Moving Average 24.97
Relative Strength Index (RSI) 33.44
Average Volume (20 Days) 139

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, FRA:M3V had revenue of EUR 16.64 million and earned 4.30 million in profits. Earnings per share was 2.36.

Revenue 16.64M
Gross Profit 5.93M
Operating Income 3.37M
Pretax Income 4.42M
Net Income 4.30M
EBITDA 3.52M
EBIT 3.37M
Earnings Per Share (EPS) 2.36
Full Income Statement

Balance Sheet

The company has 2.57 million in cash and n/a in debt, giving a net cash position of 2.57 million.

Cash & Cash Equivalents 2.57M
Total Debt n/a
Net Cash 2.57M
Net Cash Per Share n/a
Equity (Book Value) 17.83M
Book Value Per Share 9.79
Working Capital 5.04M
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 35.62%, with operating and profit margins of 20.25% and 25.87%.

Gross Margin 35.62%
Operating Margin 20.25%
Pretax Margin 26.57%
Profit Margin 25.87%
EBITDA Margin 21.16%
EBIT Margin 20.25%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 0.95, which amounts to a dividend yield of 3.77%.

Dividend Per Share 0.95
Dividend Yield 3.77%
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield 3.77%
Earnings Yield 9.38%
FCF Yield n/a
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

FRA:M3V has an Altman Z-Score of 6.45.

Altman Z-Score 6.45
Piotroski F-Score n/a